| human | Q5 |
| P496 | ORCID iD | 0000-0002-3110-7746 |
| P69 | educated at | University of Glasgow | Q192775 |
| P734 | family name | Stott | Q37238730 |
| Stott | Q37238730 | ||
| Stott | Q37238730 | ||
| P735 | given name | David | Q18057751 |
| David | Q18057751 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q38992531 | 4C.03: SHORT-TERM HEART RATE VARIABILITY AND COGNITIVE FUNCTION IN OLDER SUBJECTS AT RISK OF CARDIOVASCULAR DISEASE. |
| Q24794358 | A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics |
| Q28267020 | A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease |
| Q38776088 | A genome-wide interaction analysis of tricyclic/tetracyclic antidepressants and RR and QT intervals: a pharmacogenomics study from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium |
| Q36468916 | A meta-analysis of 120 246 individuals identifies 18 new loci for fibrinogen concentration |
| Q34585754 | A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function |
| Q83716294 | A prospective study using the ABCD2 score in screening for minor stroke or transient ischaemic attack in referrals to a fast track clinic |
| Q92915125 | A smartphone-based test for the assessment of attention deficits in delirium: A case-control diagnostic test accuracy study in older hospitalised patients |
| Q64450112 | AD-8 for detection of dementia across a variety of healthcare settings |
| Q24194796 | AD-8 for diagnosis of dementia across a variety of healthcare settings |
| Q57606177 | ASSOCIATION OF BLOOD PRESSURE LOWERING MEDICATION WITH VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY AND COGNITIVE FUNCTION IN OLD AGE |
| Q43209056 | Activation of hemostasis and decline in cognitive function in older people |
| Q46295029 | Adipocytokines and risk of stroke in older people: a nested case-control study |
| Q80438418 | An internationally agreed definition of progressing stroke |
| Q46230616 | Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderly |
| Q33474334 | Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events? |
| Q62477907 | Assessment of the Relationship Between Genetic Determinants of Thyroid Function and Atrial Fibrillation: A Mendelian Randomization Study |
| Q91001733 | Association Between Levothyroxine Treatment and Thyroid-Related Symptoms Among Adults Aged 80 Years and Older With Subclinical Hypothyroidism |
| Q46916876 | Association between apolipoprotein E4 and cognitive decline in elderly adults |
| Q37219260 | Association between cognition and gene polymorphisms involved in thrombosis and haemostasis |
| Q92528135 | Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events |
| Q95834209 | Association of High-Density Lipoprotein Cholesterol With Cognitive Function: Findings From the PROspective Study of Pravastatin in the Elderly at Risk |
| Q57047818 | Association of Thyroid Hormone Therapy With Quality of Life and Thyroid-Related Symptoms in Patients With Subclinical Hypothyroidism: A Systematic Review and Meta-analysis |
| Q58065025 | Association of alcohol consumption with allergic disease and asthma: a multi-centre Mendelian randomization analysis |
| Q103836081 | Association of circulating metabolites in plasma or serum and risk of stroke: Meta-analysis from seven prospective cohorts |
| Q99349673 | Association of common genetic variants with brain microbleeds: A Genome-wide Association Study |
| Q47355429 | Association of complement receptor 1 gene polymorphisms with cognitive function |
| Q44175624 | Association of visit-to-visit variability in blood pressure with cognitive function in old age: prospective cohort study |
| Q86404361 | Associations Between Thrombin Generation and the Risk of Cardiovascular Disease in Elderly Patients: Results From the PROSPER Study |
| Q46023236 | Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke. |
| Q74265800 | Atherogenic lipid profile in elderly patients with ischaemic cerebrovascular disease |
| Q64076271 | Author Correction: Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function |
| Q51039930 | Barriers to delivery of thrombolysis for acute stroke. |
| Q37849480 | Barthel index for stroke trials: development, properties, and application. |
| Q51108086 | Biological correlates of blood pressure variability in elderly at high risk of cardiovascular disease. |
| Q50578868 | Blood Pressure Lowering Medication, Visit-to-Visit Blood Pressure Variability, and Cognitive Function in Old Age. |
| Q34533910 | Blood pressure variability and cardiovascular risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). |
| Q57653798 | C-Reactive Protein and Prediction of Coronary Heart Disease and Global Vascular Events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) |
| Q28740683 | C-reactive protein and genetic variants and cognitive decline in old age: the PROSPER study |
| Q33337548 | Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies |
| Q83202085 | Cerebral microbleeds are predictive of mortality in the elderly |
| Q104134943 | Cerebral small vessel disease genomics and its implications across the lifespan |
| Q57231937 | Circulating Interleukin-10 and Risk of Cardiovascular Events |
| Q50913733 | Circulating interleukin-6 concentration and cognitive decline in old age: the PROSPER study. |
| Q39488695 | Cognitive assessment in stroke: feasibility and test properties using differing approaches to scoring of incomplete items |
| Q96227493 | Common Genetic Variation Indicates Separate Causes for Periventricular and Deep White Matter Hyperintensities |
| Q30490746 | Comparison of HapMap and 1000 Genomes Reference Panels in a Large-Scale Genome-Wide Association Study |
| Q95409761 | Comprehensive Geriatric Assessment in hospital and hospital-at-home settings: a mixed-methods study |
| Q46491161 | Contrasting associations of insulin resistance with diabetes, cardiovascular disease and all-cause mortality in the elderly: PROSPER long-term follow-up |
| Q48622953 | D-dimer predicts early clinical progression in ischemic stroke: confirmation using routine clinical assays |
| Q34441746 | Defining the role of common variation in the genomic and biological architecture of adult human height |
| Q90285790 | Delirium in an Acute Stroke Setting, Occurrence, and Risk Factors |
| Q35162484 | Developing and evaluating the implementation of a complex intervention: using mixed methods to inform the design of a randomised controlled trial of an oral healthcare intervention after stroke |
| Q58732904 | Diagnostic test accuracy of a novel smartphone application for the assessment of attention deficits in delirium in older hospitalised patients: a prospective cohort study protocol |
| Q36009501 | Discovery of Genetic Variation on Chromosome 5q22 Associated with Mortality in Heart Failure |
| Q33730106 | Do vascular risk factors explain the association between socioeconomic status and stroke incidence: a meta-analysis |
| Q46191723 | Does low to moderate alcohol intake protect against cognitive decline in older people? |
| Q28550578 | Drug-Gene Interactions of Antihypertensive Medications and Risk of Incident Cardiovascular Disease: A Pharmacogenomics Study from the CHARGE Consortium |
| Q37154348 | Drug-gene interactions and the search for missing heritability: a cross-sectional pharmacogenomics study of the QT interval |
| Q96642955 | Effect of Thyroid Hormone Therapy on Fatigability in Older Adults With Subclinical Hypothyroidism: A Nested Study Within a Randomized Placebo-Controlled Trial |
| Q30833390 | Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals |
| Q37538310 | Elevated troponin after stroke: a systematic review |
| Q40396259 | Evaluation of delirium screening tools in geriatric medical inpatients: a diagnostic test accuracy study |
| Q46972338 | Feasibility and diagnostic accuracy of early mood screening to diagnose persisting clinical depression/anxiety disorder after stroke |
| Q36490016 | GWAS for executive function and processing speed suggests involvement of the CADM2 gene. |
| Q38802893 | Genetic Risk Prediction of Atrial Fibrillation |
| Q57653794 | Genetic Variation in the Interleukin-10 Gene Promoter and Risk of Coronary and Cerebrovascular Events: The PROSPER Study |
| Q57143829 | Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits |
| Q57399039 | Genetic analysis of over one million people identifies 535 novel loci for blood pressure |
| Q61807445 | Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting |
| Q34667790 | Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N=53949). |
| Q34985395 | Genetic predictors of fibrin D-dimer levels in healthy adults |
| Q47656981 | Genetic variation in galectin-3 gene associates with cognitive function at old age. |
| Q46729948 | Genetic variation in the interleukin-1 beta-converting enzyme associates with cognitive function. The PROSPER study |
| Q58618794 | Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders |
| Q28652132 | Genome of The Netherlands population-specific imputations identify an ABCA6 variant associated with cholesterol levels |
| Q35948055 | Genome-Wide Association Study for Incident Myocardial Infarction and Coronary Heart Disease in Prospective Cohort Studies: The CHARGE Consortium |
| Q90215760 | Genome-Wide Association Study of Apparent Treatment-Resistant Hypertension in the CHARGE Consortium: The CHARGE Pharmacogenetics Working Group |
| Q62477913 | Genome-Wide Association Transethnic Meta-Analyses Identifies Novel Associations Regulating Coagulation Factor VIII and von Willebrand Factor Plasma Levels |
| Q40408213 | Genome-wide Trans-ethnic Meta-analysis Identifies Seven Genetic Loci Influencing Erythrocyte Traits and a Role for RBPMS in Erythropoiesis |
| Q58061656 | Genome-wide analyses identify a role for SLC17A4 and AADAT in thyroid hormone regulation |
| Q92527797 | Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure |
| Q57399037 | Genome-wide association meta-analysis of PR interval identifies 47 novel loci associated with atrial and atrioventricular electrical activity |
| Q33920700 | Genome-wide association meta-analysis of human longevity identifies a novel locus conferring survival beyond 90 years of age. |
| Q37351431 | Genome-wide association studies identify genetic loci for low von Willebrand factor levels |
| Q41507893 | Genome-wide association studies identify genetic loci for low von Willebrand factor levels |
| Q28658007 | Genome-wide association study for circulating tissue plasminogen activator levels and functional follow-up implicates endothelial STXBP5 and STX2. |
| Q36241862 | Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure |
| Q58695684 | Genome-wide association study of 23,500 individuals identifies 7 loci associated with brain ventricular volume |
| Q30352681 | Genome-wide meta-analysis of 241,258 adults accounting for smoking behaviour identifies novel loci for obesity traits. |
| Q91736532 | Genome-wide meta-analysis of variant-by-diuretic interactions as modulators of lipid traits in persons of European and African ancestry |
| Q28729086 | Genome-wide study of gene variants associated with differential cardiovascular event reduction by pravastatin therapy |
| Q47792505 | Hemostatic function and progressing ischemic stroke: D-dimer predicts early clinical progression |
| Q85056027 | High Innate Production Capacity of Proinflammatory Cytokines Increases Risk for Death from Cancer: Results of the PROSPER Study |
| Q38657042 | High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants |
| Q48901180 | High-sensitivity cardiac troponin T is associated with cognitive decline in older adults at high cardiovascular risk |
| Q34516430 | Homocysteine levels and treatment effect in the PROspective Study of Pravastatin in the Elderly at Risk |
| Q79893361 | Homocysteine, B vitamins, and cardiovascular disease |
| Q51925255 | Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus study. |
| Q79253724 | IGF-1 levels, leg extensor power and physical performance after proximal femoral fracture |
| Q24200918 | IQCODE for the diagnosis of Alzheimer’s disease dementia and other dementias within a community setting |
| Q24197665 | IQCODE for the diagnosis of Alzheimer’s disease dementia and other dementias within a general practice (primary care) setting |
| Q24197672 | IQCODE for the diagnosis of Alzheimer’s disease dementia and other dementias within a secondary care setting |
| Q88916885 | Impact of Thyroid Hormone Therapy on Atherosclerosis in the Elderly With Subclinical Hypothyroidism: A Randomized Trial |
| Q38253591 | Impact of a clinical pathway on end-of-life care following stroke: a mixed methods study. |
| Q48313636 | Improved survival after stroke |
| Q44824891 | In search for genetic determinants of clinically meaningful differential cardiovascular event reduction by pravastatin in the PHArmacogenetic study of Statins in the Elderly at risk (PHASE)/PROSPER study. |
| Q33826794 | Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). |
| Q24194747 | Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a general practice (primary care) setting |
| Q24187059 | Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a secondary care setting |
| Q24194962 | Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within community dwelling populations |
| Q24193211 | Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early diagnosis of dementia across a variety of healthcare settings |
| Q30240898 | Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early diagnosis of dementia across a variety of healthcare settings. |
| Q35133033 | Informant single screening questions for delirium and dementia in acute care--a cross-sectional test accuracy pilot study |
| Q35076011 | International variation in GP treatment strategies for subclinical hypothyroidism in older adults: a case-based survey |
| Q30275308 | KLB is associated with alcohol drinking, and its gene product β-Klotho is necessary for FGF21 regulation of alcohol preference |
| Q94513311 | L-Thyroxine Therapy for Older Adults With Subclinical Hypothyroidism and Hypothyroid Symptoms: Secondary Analysis of a Randomized Trial |
| Q33790423 | Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group. |
| Q37067123 | Leptin predicts diabetes but not cardiovascular disease: results from a large prospective study in an elderly population |
| Q83759243 | Letter by Langhorne and Stott regarding article, "Very early mobilization after stroke fast-tracks return to walking: further results from the phase II AVERT randomized controlled trial" |
| Q43224125 | Lipoprotein-associated phospholipase A(2), inflammatory biomarkers, and risk of cardiovascular disease in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). |
| Q34983980 | Long-term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) |
| Q52569939 | Low thyroid function is not associated with an accelerated deterioration in renal function. |
| Q46574817 | Lymphotoxin-alpha C804A polymorphism is a risk factor for stroke. The PROSPER study |
| Q89449155 | Managing blood pressure in older adults |
| Q48987597 | Markers of endothelial dysfunction and cerebral blood flow in older adults |
| Q92796569 | Measuring the effects of listening for leisure on outcome after stroke (MELLO): A pilot randomized controlled trial of mindful music listening |
| Q30276013 | Meta-analysis of genome-wide association studies of HDL cholesterol response to statins |
| Q50531000 | Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. |
| Q80804718 | Multidisciplinary care for elderly people in the community |
| Q35592807 | Multiethnic genome-wide association study of cerebral white matter hyperintensities on MRI |
| Q28661433 | Multiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease |
| Q48709088 | N-terminal pro-brain natriuretic peptide and cognitive decline in older adults at high cardiovascular risk |
| Q89901236 | New horizons in iron deficiency anaemia in older adults |
| Q57605593 | Ninety-nine independent genetic loci influencing general cognitive function include genes associated with brain health and structure (N = 280,360) |
| Q34796836 | No evidence for genome-wide interactions on plasma fibrinogen by smoking, alcohol consumption and body mass index: results from meta-analyses of 80,607 subjects |
| Q30596587 | Non-homologous end-joining pathway associated with occurrence of myocardial infarction: gene set analysis of genome-wide association study data |
| Q36688483 | Non-response to (statin) therapy: the importance of distinguishing non-responders from non-adherers in pharmacogenetic studies |
| Q38663648 | Novel Blood Pressure Locus and Gene Discovery Using Genome-Wide Association Study and Expression Data Sets From Blood and the Kidney |
| Q37598396 | Novel genetic loci associated with hippocampal volume |
| Q27653381 | Novel genetic loci underlying human intracranial volume identified through genome-wide association |
| Q33563000 | Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese |
| Q54965217 | Outcomes, experiences and palliative care in major stroke: a multicentre, mixed-method, longitudinal study. |
| Q36658435 | PCSK9 SNP rs11591147 is associated with low cholesterol levels but not with cognitive performance or noncardiovascular clinical events in an elderly population |
| Q57258977 | PR interval genome-wide association meta-analysis identifies 50 loci associated with atrial and atrioventricular electrical activity |
| Q59544442 | Participants’ experiences of music, mindful music, and audiobook listening interventions for people recovering from stroke |
| Q34453666 | Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins |
| Q64450128 | Planning Cardiovascular Investigations and Management of Older People |
| Q46795019 | Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). |
| Q43298984 | Pravastatin and cognitive function in the elderly. Results of the PROSPER study |
| Q29617817 | Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial |
| Q43516697 | Predictors of early neurological deterioration after ischaemic stroke: a case-control study |
| Q80357229 | Predictors of functional decline in elderly people with vascular risk factors or disease |
| Q90945261 | Prevalence of pre-stroke depression and its association with post-stroke depression: a systematic review and meta-analysis |
| Q59566858 | Publisher Correction: Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits |
| Q64121305 | Publisher Correction: Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits |
| Q80727556 | Randomised controlled trial of electrical stimulation of the quadriceps after proximal femoral fracture |
| Q81583346 | Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease |
| Q33402590 | Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis |
| Q47106476 | Reduced level of arousal and increased mortality in adult acute medical admissions: a systematic review and meta-analysis |
| Q38072601 | Reliability (inter-rater agreement) of the Barthel Index for assessment of stroke survivors: systematic review and meta-analysis. |
| Q34041800 | Replication of LDL GWAs hits in PROSPER/PHASE as validation for future (pharmaco)genetic analyses |
| Q85727508 | Resting heart rate and incident heart failure and cardiovascular mortality in older adults: role of inflammation and endothelial dysfunction: the PROSPER study |
| Q36176970 | Resting heart rate, heart rate variability and functional decline in old age. |
| Q51902503 | Risk factors for chest infection in acute stroke: a prospective cohort study. |
| Q52146491 | Risk stratification and treatment effect of statins in secondary cardiovascular prevention in old age: Additive value of N-terminal pro-B-type natriuretic peptide. |
| Q37600673 | STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease |
| Q64954354 | Should I stay or should I go? A retrospective propensity score-matched analysis using administrative data of hospital-at-home for older people in Scotland. |
| Q84930290 | Should oral nutritional supplementation be given to undernourished older people upon hospital discharge? A controlled trial |
| Q26992137 | Single screening questions for cognitive impairment in older people: a systematic review |
| Q91183822 | Skeletal Effects of Levothyroxine for Subclinical Hypothyroidism in Older Adults: A TRUST Randomized Trial Nested Study |
| Q82617390 | Socioeconomic Status and Transient Ischaemic Attack/Stroke: A Prospective Observational Study |
| Q90745099 | Spatial QRS-T Angle and Cognitive Decline in Older Subjects |
| Q64450117 | Statin Use is Not Associated with Future Long-Term Care Admission: Extended Follow-Up of Two Randomised Controlled Trials |
| Q29622947 | Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials |
| Q55005079 | Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function |
| Q58719083 | Study protocol: a randomised controlled trial on the clinical effects of levothyroxine treatment for subclinical hypothyroidism in people aged 80 years and over |
| Q36270288 | Study protocol; Thyroid hormone Replacement for Untreated older adults with Subclinical hypothyroidism - a randomised placebo controlled Trial (TRUST). |
| Q30927999 | Subclinical Hypothyroidism and the Risk of Stroke Events and Fatal Stroke: An Individual Participant Data Analysis |
| Q40705575 | Subclinical Thyroid Dysfunction and Depressive Symptoms among the Elderly: A Prospective Cohort Study. |
| Q57530044 | Subclinical Thyroid Dysfunction and the Risk of Heart Failure in Older Persons at High Cardiovascular Risk |
| Q95380031 | Subclinical thyroid disorders |
| Q31114507 | Subclinical thyroid dysfunction and cognitive decline in old age |
| Q34477885 | Subclinical thyroid dysfunction and fracture risk: a meta-analysis |
| Q37587984 | Subclinical thyroid dysfunction and functional capacity among elderly. |
| Q92522162 | Subsequent Event Risk in Individuals With Established Coronary Heart Disease |
| Q38246217 | Test accuracy of cognitive screening tests for diagnosis of dementia and multidomain cognitive impairment in stroke. |
| Q35469518 | Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at Risk |
| Q44153716 | The Cochrane Collaboration and geriatric medicine. |
| Q42746670 | The Dilemma of Treating Subclinical Hypothyroidism: Risk that Current Guidelines Do More Harm than Good. |
| Q90327440 | The Impact of Levothyroxine on Cardiac Function in Older Adults with Mild Subclinical Hypothyroidism: a Randomized Clinical Trial |
| Q57418605 | The Relation Between Thyroid Function and Anemia: A Pooled Analysis of Individual Participant Data |
| Q90079322 | The association of kidney function and cognitive decline in older patients at risk of cardiovascular disease: a longitudinal data analysis |
| Q57653855 | The design of a prospective study of pravastatin in the elderly at risk (PROSPER) |
| Q46503491 | The incidence and risk factors for new onset atrial fibrillation in the PROSPER study |
| Q82897250 | The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes |
| Q92043216 | The kidney, subclinical thyroid disease and cardiovascular outcomes in older patients |
| Q95305613 | The work of older people and their informal caregivers in managing an acute health event in a hospital at home or hospital inpatient setting |
| Q38798082 | Thyroid Function Tests in the Reference Range and Fracture: Individual Participant Analysis of Prospective Cohorts. |
| Q46345650 | Thyroid Function Within the Normal Range, Subclinical Hypothyroidism, and the Risk of Atrial Fibrillation |
| Q31127196 | Thyroid Function Within the Reference Range and the Risk of Stroke: An Individual Participant Data Analysis |
| Q40246242 | Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism. |
| Q46889804 | Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism. |
| Q30936906 | Thyroid function within the normal range and risk of coronary heart disease: an individual participant data analysis of 14 cohorts |
| Q44792796 | Thyroid-stimulating hormone and clinical outcomes: the CORONA trial (controlled rosuvastatin multinational study in heart failure). |
| Q34495057 | Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation |
| Q54312370 | Unraveling the Directional Link between Adiposity and Inflammation: A Bidirectional Mendelian Randomization Approach. |
| Q33586820 | Unraveling the directional link between adiposity and inflammation: a bidirectional Mendelian randomization approach |
| Q39673001 | Validity and reliability of estimating the scandinavian stroke scale score from medical records |
| Q59611199 | Very Early Rehabilitation or Intensive Telemetry after Stroke: A Pilot Randomised Trial |
| Q39813799 | Volunteer Stroke Service (VSS) groups for patients with communication difficulties after stroke: a qualitative analysis of the value of groups to their users |
| Q28601040 | White Matter Lesion Progression: Genome-Wide Search for Genetic Influences |
| Q84843327 | Xerostomia after acute stroke |
Search more.